Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Role of the Presenilin1mediated Cleavage of Ephrin B Proteins Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant

Role of the Presenilin1mediated Cleavage of Ephrin B Proteins

BFF logo

Principal Investigator

Anastasios Georgakopoulos, PhD

Icahn School of Medicine at Mount Sinai

New York, NY, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$200,000

Active Dates

April 01, 2003 - March 31, 2005

Grant ID

A2003031

Summary

Alzheimer’s disease (AD) is a neurodegenerative disorder of the central nervous system (CNS). There are at least two forms of AD: the sporadic form, which inflicts most AD patients and usually occurs after the age of 65 or 70, and the familial form, which occurs at earlier stages and follows a more rapid progressive course than the sporadic disease. Familial AD (FAD) is caused by mutations in certain genes, including the amyloid precursor protein (APP) gene, presenilin-1 (PS1), and presenilin-2 (PS2). PS1 mutations are responsible for most cases of FAD. It was recently demonstrated that PS1 controls the γ-secretase-mediated cleavage of several type I transmembrane proteins like the APP, Notch, erbB4, CD44 and E-cadherin. EphrinB proteins are type I transmembrane proteins that are ligands for the ephrinB receptors (EphBs). Both proteins are expressed in the CNS and are also found at the neuronal synapses, where they play a very important role in the synaptic function affecting memory. The goal of this study is to investigate the role of PS1-dependent γ-secretase-like activity in the processing and function of ephrinB proteins.